mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.0009 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |